Pre-Congress Events

The following event/s will occur prior to the World Hospital Congress, and are listed below for the convenience of delegates who may be interested in attending. Information on how to register for each pre-Congres event is listed in the details below.

Potentially Preventable HospitalisationsRedefining HealthcareHIMAA one day symposium Clinical Trials in Queensland

“Potentially Preventable Hospitalisations” thought-leadership forum

Date and time: Tuesday 9 October 2018 at 9.00am – 5.00pm
Venue: Brisbane Convention & Exhibition Centre
Cost: free

Potentially preventable hospitalisations (PPH) have been defined as those hospitalisations which could have been avoided with access to quality primary care and preventative care. ACSQHC, 2009.

Novartis will host a one day thought-leadership forum on Potentially Preventable Hospitalisation on 9 October, the day before the formal commencement of the World Hospital Congress. This session is free to attend by registrants of the 2018 World Hospital Congress*.

Potentially preventable hospitalisations is a critical whole-of-health issue and addressing this problem requires dedicated commitment by stakeholders across the health system.

The Novartis thought-leadership forum will bring together a small but diverse group of stakeholders to engage in facilitated discussion, idea sharing and information exchange. Over the course of the day, four sector experts will lead round-table conversations on a variety of key issues. 

The provisional sessions themes are:

  • Integration of care and conditions of ‘potentially preventable hospitalisations’
  • The importance of patient experience, community engagement and health literacy
  • Quality, safety and measurable health outcomes
  • Interventions, innovations, and strategies

The forum aims to bring people together to create connections, spark new ideas and contribute to solving this critical issue.

The “Potentially Preventable Hospitalisations” thought-leadership forum has limited places available and attendance is via an Expression of Interest process. To express your interest, email with your name, title, contact details and a short, one paragraph outline of insights and experiences you wish to share to the day.

Aspiring to create a diverse group of stakeholders, the final list of applicants will be notified by 21 September 2018.

* Note: There is no cost for successful applicants to attend the forum, however any ancillary costs related to attendance including but not limited to travel and accommodation are the responsibility of the applicant. 

For more information, including the detailed agenda and speakers click here.


Redefining Healthcare

Date and time: Monday 8 and Tuesday 9 October 2018 at 9.00am – 5.00pm
Venue: P Block – Science and Engineering Centre, QUT
Cost: $1,800

Join Professors Elizabeth Teisberg, Scott Wallace, and Alice Andrews for this two-day program providing a comprehensive overview of value-based health care.

This workshop develops actionable insight through facilitated dialogue among participants, including discussion of Dell Medical School's integrated practice units. It will explore concepts and frameworks of value-based care delivery, such as understanding patient segments, identifying opportunities to improve current services, measuring meaningful outcomes, accelerating learning in clinical teams, and achieving new payment models. If you are making the transition from volume-to-value, we hope you will join us. 
As leaders across health care embrace the concept of value, many are seeking ways to accelerate transformation within their organizations. Please join Dell Medical School Professors Elizabeth Teisberg, Scott Wallace, and Alice Andrews for a two-day interactive dialogue among leaders in value-based health care.

For more information or to register click here.



Date and Time: 9 October 2018 at 9.00am – 4.00pm
Venue: Brisbane Convention and Exhibition Centre plus a hospital site visit
Cost: $100 AHHA and HIMAA Members, $140 standard price

What is happening in your part of the world in implementing electronic health record systems, such as Electronic Medical Record systems or Electronic Health Records?

At what stage in the HIMSS EMR Adoption Model (EMRAM) is your country?

In Australia five years ago a national report [1] estimated that half of the hospitals in Australia were at HIMSS EMRAM Stage 2, and not much above that. By comparison, over 75% of US hospitals were at Stage 3 and above, and in Canada and Europe the number at Stage 2 and above was greater than the number below. In the rest of the Asia Pacific region, the number below Stage 2 (62%) was the greater. In the last five years there has been continued maturity and progress in EMR/EHR adoption around the world.

The implementation of EMR/EHRs presents many challenges from a planning, implementation and ongoing governance perspective.

The Health Information Management Association of Australia (HIMAA) has been serving the health information management profession in Australia since 1949. In this one day symposium, HIMAA is inviting health information professionals and others interested in the digitisation of health information from hospitals around the world to a morning workshop.

Participants will be asked to share their experiences of EMR/EHR implementation to date with a view to identifying some of the challenges and pitfalls, and solutions to these that have been found in their home countries. Discussion will include information governance. By sharing challenges and solutions from around the globe, we will assist you find solutions to challenges at home.

Facilitating this exchange, former HIMAA President and Director of Information Management of the Mater Misericordiae hospital group, Sallyanne Wissmann will in turn share some learnings from Australia. A team of HIM professionals from HIMAA’s Queensland Branch will also be involved to facilitate small group discussion, so there will be plenty of contact with the local Australian HIM community.

In the afternoon, you will have the option to visit one of two local hospitals: one that is yet to purchase an EMR, but has developed a clinical portal to join together disparate patient information sources for clinical care and has a very efficient paper scanning operation (Mater Hospital), and the other is a large tertiary hospital operating at HIMSS EMRAM Stage 7 (Princess Alexandra).  

For more information, contact HIMAA’s Marketing & Events Manager, Milla Krivozhnya


Global advantage and practical guidance for conducting clinical trials in Queensland

Date and time: Tuesday 9 October 2018 at  2.30pm - 4.30pm
Venue: Meeting Room 14.07, Level 14, 33 Charlotte Street, Brisbane
Cost: free

Queensland is one of the world's most attractive locations for clinical trials. The state hosts world-class researchers and clinicians, leading healthcare and research infrastructure, state- of-the-art medical research facilities and laboratories, a stable socio-political environment, robust intellectual property frameworks, and a simple and efficient regulatory framework for clinical research. Queensland provides a one-stop-shop for navigating the clinical trials pathway. We have access to state-wide patients (including ethnically diverse populations) and can connect with clinical trial service providers. Queensland has an outstanding clinical trial capability  in conducting thousands of clinical trials across hundreds of clinical trial sites including early phase research
Health Innovation, Investment and Research Office (HIIRO) of Department of Health, Queensland will host a two-hour workshop on Global advantage and practical guidance for conducting clinical trials in Queensland on 9 October. The workshop aims to provide international partners a comprehensive knowledge on Queensland Health’s capacity in conducting clinical trials and guidelines on how to conduct clinical trials in Queensland.
Key topics will include:

  • Areas with strengths in Queensland
  • Clinical trial coordination
  • Quality and international standards on clinical trials
  • Efficient regulatory framework
  • Cost advantages for conducting clinical trials in Queensland

To register, please email your name, title and contact details by 14 September 2018.

For more information, including the detailed agenda and speakers click here.